185 related articles for article (PubMed ID: 28982392)
21. The Multiple Faces of Nervous System Lymphoma. Atypical Magnetic Resonance Imaging Features and Contribution of the Advanced Imaging.
Jiménez de la Peña MD; Vicente LG; Alonso RC; Cabero SF; Suárez AM; de Vega VM
Curr Probl Diagn Radiol; 2017; 46(2):136-145. PubMed ID: 27475832
[TBL] [Abstract][Full Text] [Related]
22. A case of lymphomatosis cerebri mimicking inflammatory diseases.
Murakami T; Yoshida K; Segawa M; Yoshihara A; Hoshi A; Nakamura K; Ichikawa M; Suzuki O; Yokoyama Y; Toyoshima Y; Sugiura Y; Ito H; Saito K; Hashimoto Y; Kakita A; Takahashi H; Ugawa Y
BMC Neurol; 2016 Aug; 16():128. PubMed ID: 27502482
[TBL] [Abstract][Full Text] [Related]
23. Primary central nervous system lymphoma initially mimicking lymphomatosis cerebri: an autopsy case report.
Sugie M; Ishihara K; Kato H; Nakano I; Kawamura M
Neuropathology; 2009 Dec; 29(6):704-7. PubMed ID: 19389079
[TBL] [Abstract][Full Text] [Related]
24. Lymphomatosis cerebri with cauda equina lymphoma.
Deng G; Tao R; Tian DS; Liu JL
Int J Neurosci; 2021 Sep; 131(9):902-908. PubMed ID: 32315551
[TBL] [Abstract][Full Text] [Related]
25. Pathologically Proven Gadolinium-enhanced MRI Lesions in the Bilateral Corticospinal Tracts in Lymphomatosis Cerebri.
Yamaura G; Ogasawara A; Ito T; Ohsugi S; Kanatsuka Y; Hayashi R; Iwashita H; Hayashi H; Koyano S; Yamaguchi S; Tanaka F
Intern Med; 2020 Nov; 59(22):2931-2934. PubMed ID: 32713909
[TBL] [Abstract][Full Text] [Related]
26. [A case of lymphomatosis cerebri rapidly confirmed by brain biopsy].
Yamaguchi N; Matsuda S; Yoshizawa T; Shigeeda R; Inoue T; Uchibori Y
Rinsho Shinkeigaku; 2019 May; 59(5):286-289. PubMed ID: 31061303
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic Accuracy of T1-Weighted Dynamic Contrast-Enhanced-MRI and DWI-ADC for Differentiation of Glioblastoma and Primary CNS Lymphoma.
Lin X; Lee M; Buck O; Woo KM; Zhang Z; Hatzoglou V; Omuro A; Arevalo-Perez J; Thomas AA; Huse J; Peck K; Holodny AI; Young RJ
AJNR Am J Neuroradiol; 2017 Mar; 38(3):485-491. PubMed ID: 27932505
[TBL] [Abstract][Full Text] [Related]
28. Neurocognitive features distinguishing primary central nervous system lymphoma from other possible causes of rapidly progressive dementia.
Deutsch MB; Mendez MF
Cogn Behav Neurol; 2015 Mar; 28(1):1-10. PubMed ID: 25812125
[TBL] [Abstract][Full Text] [Related]
29. CT and MR imaging features of primary central nervous system lymphoma in Norway, 1989-2003.
Haldorsen IS; Kråkenes J; Krossnes BK; Mella O; Espeland A
AJNR Am J Neuroradiol; 2009 Apr; 30(4):744-51. PubMed ID: 19164442
[TBL] [Abstract][Full Text] [Related]
30. [Characteristic imaging features of primary central nervous system lymphoma in comparison with pathological findings].
Liu HY; Zhang XL; Chen YP; Qiu SJ
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Feb; 29(2):333-6. PubMed ID: 19246316
[TBL] [Abstract][Full Text] [Related]
31. [Rapidly progressive dementia associated with leukoencephalopathy: A case report of lymphomatosis cerebri].
Vences MA; Saravia-Ayala AF; Barreto-Acevedo E
Medwave; 2021 Mar; 21(2):e8138. PubMed ID: 33830973
[TBL] [Abstract][Full Text] [Related]
32. Pretreatment findings on magnetic resonance imaging in primary central nervous system lymphoma may predict overall survival duration.
Huntoon K; Makary MS; Shah VS; Aquino A; Pandya V; Giglio P; Slone HW; Elder JB
Neuroradiol J; 2023 Aug; 36(4):479-485. PubMed ID: 36715098
[TBL] [Abstract][Full Text] [Related]
33. Central nervous system lymphoma characterization by diffusion-weighted imaging and MR spectroscopy.
Zacharia TT; Law M; Naidich TP; Leeds NE
J Neuroimaging; 2008 Oct; 18(4):411-7. PubMed ID: 18494774
[TBL] [Abstract][Full Text] [Related]
34. Differentiating Glioblastoma from Primary Central Nervous System Lymphoma: The Value of Shaping and Nonenhancing Peritumoral Hyperintense Gyral Lesion on FLAIR Imaging.
Wang P; Shi YH; Li JY; Zhang CZ
World Neurosurg; 2021 May; 149():e696-e704. PubMed ID: 33548537
[TBL] [Abstract][Full Text] [Related]
35. Intravascular lymphomatosis: contribution of cerebral MRI findings to diagnosis.
Liow K; Asmar P; Liow M; Spanaki M; Townsend JJ; Buys S; Baringer JR; Osborn A
J Neuroimaging; 2000 Apr; 10(2):116-8. PubMed ID: 10800265
[TBL] [Abstract][Full Text] [Related]
36. Radiographic findings in 37 cases of primary CNS lymphoma in immunocompetent patients.
Coulon A; Lafitte F; Hoang-Xuan K; Martin-Duverneuil N; Mokhtari K; Blustajn J; Chiras J
Eur Radiol; 2002 Feb; 12(2):329-40. PubMed ID: 11870430
[TBL] [Abstract][Full Text] [Related]
37. Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma.
Raizer JJ; Koutcher JA; Abrey LE; Panageas KS; DeAngelis LM; Lis E; Xu S; Zakian KL
J Neurooncol; 2005 Jan; 71(2):173-80. PubMed ID: 15690135
[TBL] [Abstract][Full Text] [Related]
38. Is deep brain involvement in intracranial primary central nervous system lymphoma of importance for penetration of chemotherapeutic agents?
Meling TR; Latysheva A; Da Broi M; Jahr G; Holte H; Beiske K; Emblem KE
Neuroradiology; 2018 Jul; 60(7):703-713. PubMed ID: 29804159
[TBL] [Abstract][Full Text] [Related]
39. Contrast-Enhanced MRI Texture Parameters as Potential Prognostic Factors for Primary Central Nervous System Lymphoma Patients Receiving High-Dose Methotrexate-Based Chemotherapy.
Chen C; Zhuo H; Wei X; Ma X
Contrast Media Mol Imaging; 2019; 2019():5481491. PubMed ID: 31777472
[TBL] [Abstract][Full Text] [Related]
40. Primary central nervous system lymphoma and atypical glioblastoma: Differentiation using radiomics approach.
Suh HB; Choi YS; Bae S; Ahn SS; Chang JH; Kang SG; Kim EH; Kim SH; Lee SK
Eur Radiol; 2018 Sep; 28(9):3832-3839. PubMed ID: 29626238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
